Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Dutasteride and finasteride affect different cell types differently.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Large prostate links to more hair loss, but age of onset doesn't affect it.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Testosterone therapy increases bone density in older men with low testosterone levels.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.